Novo Nordisk sues Eli Lilly, alleging misleading GLP-1 advertising
CNBC
Read Full Article at CNBC →Ad Slot — In-Article (728x90)
Novo asked the court to permanently stop Lilly from running the "deceptive" ads and require the drugmaker to issue corrective advertising.
This is a summary. For the full story, read the original article at CNBC.
Original source: CNBC